A recent Senate report has revealed significant job cuts within the U.S. Department of Health and Human Services (HHS), with the majority of terminations affecting employees at the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Released on May 13, the minority report from the Senate Health Committee detailed the extent of the layoffs, which were part of a broader reduction in force announced by Health Secretary Robert F. Kennedy Jr. This move has sparked concern among many who rely on these agencies for critical health guidance and oversight. According to the report, a total of 2,519 FDA employees and 2,473 CDC employees were let go this spring. These numbers represent a substantial portion of the overall cuts within HHS. Additionally, 1,312 employees from the National Institutes of Health (NIH) were terminated. The remaining 2,117 layoffs impacted other divisions under the HHS umbrella, including the Centers for Medicare and Medicaid Services. These figures, cited directly from HHS data in the Senate report, highlight the scale of the workforce reduction across key health agencies. The report, compiled by Democrats on the Senate panel, raises questions about the potential impact on public health programs and regulatory functions. The FDA oversees drug approvals and food safety, while the CDC plays a vital role in disease prevention and outbreak response. With thousands of positions eliminated, there are concerns about the capacity of these agencies to maintain their essential services. The Senate Health Committee minority report did not specify the reasons behind the layoffs but noted the timing and scale as areas of significant concern for future health policy implementation.